The preclinical formulation of the vaccine developed by the team offered, the publication states, high levels of immunity against lethal levels of staph and MRSA in animal tests.
Researchers at Michigan State University and Harvard Medical School joined forces to develop ato a vaccine that will fight antibiotic-resistant infections.
Due to the excessive use of antibiotics, pathogens quickly develop resistance to treatments.
Antibiotic-resistant infections are estimated to have killed more than a million people worldwide in 2019, according to the World Health Organization, and there are concerns that within a few years most drugs will not be effective.
In a new study published in the journal Nature Communications, researchers, led by Xufei Huang, a professor at the Michigan State University Research Foundation, describe creating a vaccine candidate for antibiotic-resistant bacteria.
Researchers announced several breakthroughs that will help develop the carbohydrate-based vaccine and provide protection against infections caused by Staphylococcus aureus and MRSA, or methicillin-resistant Staphylococcus aureus.
The preclinical formulation of the vaccine developed by the team offered, the publication states, high levels of immunity against lethal levels of staph and MRSA in animal tests.
For this research, Xufei Huang received the 2024 Michigan State University Technology Transfer Achievement Award.
Source :Skai
I have worked in the news industry for over 10 years. I have a vast amount of experience in covering health news. I am also an author at News Bulletin 247. I am highly experienced and knowledgeable in this field. I am a hard worker and always deliver quality work. I am a reliable source of information and always provide accurate information.
